Curis Inc (CRIS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.35-1.46%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CRIS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 9.4 | 10.9 | 10.0 | 10.2 | 10.6 | 10.8 | 10.0 | 10.4 | 9.9 | 7.5 | 7.9 | 9.8 | 15.0 | 17.0 | 14.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 9.9 | 7.5 | 7.9 | 9.8 | 15.0 | 17.0 | 14.8 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | — | — | — | — | — | — | — | — | — | 18.0 | — | — | 13.7 | 12.9 | 15.5 | 13.7 |
| Operating Income | (8.8) | (5.7) | (44.5) | (48.3) | (53.0) | (42.1) | (24.9) | (24.4) | (29.3) | (49.8) | (58.0) | (56.5) | (15.9) | (9.4) | (18.6) | (7.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.0 | 0.8 | 3.9 | 4.0 | 2.8 | 3.3 | 3.7 | 3.8 | 0.2 | — |
| Interest & Investment Income | 0.3 | 0.3 | 1.8 | 2.9 | 1.1 | 0.2 | 0.1 | 0.6 | 0.7 | 0.5 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 |
| Net Interest Expenses | — | — | — | — | — | (0.2) | (0.1) | 0.2 | 3.2 | 3.5 | 2.4 | 3.0 | 3.6 | 3.7 | 0.1 | — |
| Other Non-Operating Income / Expenses | (12.4) | (1.9) | 1.2 | 0.9 | (3.7) | (3.4) | (5.0) | (7.8) | — | — | — | — | (2.9) | (2.9) | 2.2 | (2.7) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | ||||||||||||||||
| Net Income | (21.2) | (7.6) | (43.4) | (47.4) | (56.7) | (45.4) | (29.9) | (32.1) | (32.6) | (53.3) | (60.4) | (59.0) | (18.7) | (12.3) | (16.4) | (9.9) |
| Per Share | ||||||||||||||||
| Basic EPS | (9.90) | (0.58) | (6.88) | (8.96) | (12.14) | 0.50 | (0.61) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (9.90) | (0.58) | (6.88) | (8.96) | (12.14) | 0.50 | (0.61) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 2.1 | 13.2 | 6.3 | 5.3 | 4.7 | 91.6 | 48.7 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 2.1 | 13.2 | 6.3 | 5.3 | 4.7 | 91.6 | 48.7 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (5.5) | (44.3) | (48.1) | (52.8) | (41.9) | (24.8) | (24.2) | (29.2) | (49.5) | (57.8) | (56.3) | (15.7) | (9.3) | (18.5) | (7.1) |
| EBIT | (8.8) | (5.7) | (44.5) | (48.3) | (53.0) | (42.1) | (24.9) | (24.4) | (29.3) | (49.8) | (58.0) | (56.5) | (15.9) | (9.4) | (18.6) | (7.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.